Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting
about
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsEnteral feeding and its impact on the gut immune system and intestinal mucosal barrierCross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatmentThe role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in ratsThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.The COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of lifeEcology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes.Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats.Emerging roles of the microbiome in cancer.Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT.Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets.The influence of weight and gender on intestinal bacterial community of wild largemouth bronze gudgeon (Coreius guichenoti, 1874)Obesity and Metabolic Disease After Childhood CancerFecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twinsGut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.Interaction between host cells and microbes in chemotherapy-induced mucositis.The role of oral flora in the development of chemotherapy-induced oral mucositis.The Potential Role of Probiotics in Cancer Prevention and Treatment.Gut microbiota and hematopoietic stem cell transplantation: where do we stand?The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.Microbiota: a key orchestrator of cancer therapy.Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.Risk factors associated with Clostridium difficile infection in adult oncology patients.Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia.16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.Intestinal Ralstonia pickettii augments glucose intolerance in obesity.Bacterial Diversity in Traditional Doogh in Comparison to Industrial Doogh.5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro.Evaluating the effect of Clostridium difficile conditioned medium on fecal microbiota community structure.The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.Using bugs as drugs: Microbial ecosystem therapeutics.
P2860
Q26771113-A0FF002E-416D-4C10-8C87-9470B6D4AC0EQ26777672-023EE496-B342-41EA-82C7-200D32F685F6Q28076294-74C02BAA-07B2-41C2-B295-09AD3805D5FAQ28538671-7C22B1F4-10B3-424D-B1F2-03DF7A04E1DDQ31144277-33E02858-614F-451C-9A78-3F82F113D441Q33713040-5D25EA9C-7A63-4B64-98C3-C78514372C01Q33779212-7352D97B-0E94-4C0B-90E9-DD03FFEB6E56Q34612756-AA4C5B59-B4C2-4B52-87CB-C285F421E2EDQ34716086-1299A665-D2D4-43EF-8924-0D7B1EDED4B8Q35058372-D9E5D813-357C-42DD-827B-FE0BF9E5D05FQ35109394-49C2AD75-46F9-4B89-8AF6-132F300F2A44Q35209399-D91AA0CB-C354-4D15-A03B-3427BF6EC986Q35346303-8022C3FA-AFC7-47EB-9C64-4F0B114E6B20Q35532177-62313B86-B107-4C79-8A8F-6287B6D2C676Q35609707-77947818-0732-44F6-9B9E-2A9BB7A4D6D7Q35644295-2C50C87F-B046-428D-B21E-4CC315AA0D87Q36109448-34A99D4D-1AB3-4DF2-B1B9-373021CE7372Q36588407-B02FF754-F52F-48A7-8E5A-A9FCB0D00E11Q36746790-F945D0F6-78FB-48F1-8292-0AFA4EF8EB64Q36889936-90AF26EF-9468-4DB7-B097-D59730547F3BQ38102867-52F7D8F0-2843-4BCB-98CF-E82DFFDE2351Q38185099-AA5F77C2-3EBD-4B54-8FCA-7B13EF6A11E8Q38825153-6B0D44EA-BE0E-4446-8B1C-ACA746020B0AQ38878477-DE30829B-E0B6-468C-A1BE-6D4588DB60DBQ39035437-195E10D0-418A-4CDD-AA43-07F7E785D147Q39183428-C18E3B5F-D4F7-4930-A9DF-5C2963936E9AQ39357618-4BF9E927-7623-4B59-82FF-7F73FB866867Q40129363-CFA58285-051E-435E-9375-8AFCC70D97A3Q41655888-7D5419D4-F58F-425B-A6D4-E505339103BEQ41993143-01227576-A6B7-472E-A546-783EFFE93C67Q42702938-0A5321C0-7805-48EB-95A7-EF321A2F2761Q43548235-DE27872A-9FA4-453B-A2E3-B4385A5CA183Q46256007-AD088615-1145-4380-AECA-5E1ACE58E31DQ46256413-8C869C62-1FA1-4D3B-8251-9265D9875C19Q46257516-7F40B4F3-451C-454A-AF79-1F6406547286Q47119137-F37012EE-9DE6-44B8-9417-2B749AF33DA5Q47425267-F00DE996-0176-4C30-8845-00A3C544ED37Q52349005-342FF894-421A-433D-9CC5-3ED03C394547Q53688957-348209B8-98B9-4B80-B8CF-5B78762F17DBQ54207972-8AE7BE9A-649C-47C0-BE4B-9D747D978465
P2860
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@ast
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@en
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@nl
type
label
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@ast
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@en
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@nl
prefLabel
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@ast
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@en
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@nl
P2093
P2860
P1433
P1476
Changes in human fecal microbi ...... ng and PCR-DGGE fingerprinting
@en
P2093
Alexander G Haslberger
Angelika Pointner
Berit Hippe
Cornelia Lassl
Elvira Kitzweger
Jutta Zwielehner
Marlene Remely
Olivier J Switzeny
Reinhard Ruckser
P2860
P304
P356
10.1371/JOURNAL.PONE.0028654
P407
P577
2011-12-14T00:00:00Z